The greatest risk factor for Alzheimer’s disease (AD) is advancing age. By age 85, the likelihood of developing the dreaded neurological disorder is roughly 50 percent. But researchers at the University of California, San Diego School of Medicine say AD hits hardest among the “younger elderly” – people in their 60s and 70s – who show faster rates of brain tissue loss and cognitive decline than AD patients 80 years and older.
Tai Ming Cheung has been appointed director of the University of California Institute on Global Conflict and Cooperation (IGCC), a multi-campus research unit (MRU) located on the campus of the University of California, San Diego. IGCC focuses on security and nuclear proliferation and examines how policy affects the state of conflict and peace.
Researchers at the University of California, San Diego School of Medicine have identified a link between patients who undergo total nephrectomy - complete kidney removal - and erectile dysfunction. Results from the multi-center study were recently published online in the British Journal of Urology International.
Using a new assay method to study tumor cells, researchers at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center have found evidence of clonal evolution in chronic lymphocytic leukemia (CLL). The assay method distinguishes features of leukemia cells that indicate whether the disease will be aggressive or slow-moving, a key factor in when and how patients are treated.
A study conducted by researchers from the University of California, San Diego School of Medicine along with colleagues from Rural/Metro Ambulance San Diego and the San Diego Fire-Rescue Department, shows that emergency medical personnel can obtain an electrocardiogram (ECG) in the field for chest pain patients without an increase in scene time or transport time to the hospital.
For Nobel laureate Roger Tsien, the drive to help find a cure for cancer stems from personal experience. His father battled prostate cancer and ultimately lost his life to pancreatic cancer. As a professor of pharmacology, chemistry and biochemistry at UC San Diego and a Howard Hughes Medical Institute investigator, he has worked to develop a novel way to image and possibly even deliver specially targeted drugs to cancer tumors.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
